PharVision Advisers’s EVgo EVGO Stock Holding History

PharVision Advisers’s Portfolio EVGO Stock Details EVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-122,843	Closed	-$357K	–	280
2025 Q4	$357K	Buy	122,843 +102,754	+511%	+$373K	0.18%	179
2025 Q3	$95K	Buy	+20,089	New	+$77.9K	0.05%	627

Other funds holding EVGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

SIR Capital Management New York $1.07B AUM 57.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PharVision Advisers's EVGO Position: Q1 2026 in Review

PharVision Advisers sold out of EVgo (EVGO) in Q1 2026, closing a stake of 122,843 shares — an estimated $357K sold.

PharVision Advisers first reported a position in EVGO in Q3 2025 and held it in 2 quarters. The position peaked at $357K in Q4 2025. 190 funds tracked by Wall St. Rank hold EVGO as of Q1 2026.

PharVision Advisers reported no remaining EVgo position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 122,843 EVgo shares in Q1 2026, an estimated $357K.
PharVision Advisers first reported a position in EVgo in Q3 2025 and held it in 2 quarters.
PharVision Advisers's EVgo position peaked at $357K in Q4 2025.
190 funds tracked by Wall St. Rank held EVgo as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.